LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 45 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,804,737,000 | -0.6% | 9,788,000 | -1.9% | 0.01% | +7.7% |
| Q2 2021 | $9,861,357,000 | +2.6% | 9,978,000 | +7.5% | 0.01% | -7.1% |
| Q1 2021 | $9,608,369,000 | +37.5% | 9,283,000 | +25.0% | 0.01% | +7.7% |
| Q4 2020 | $6,986,851,000 | -13.1% | 7,425,000 | -16.7% | 0.01% | +18.2% |
| Q3 2020 | $8,037,287,000 | +266.6% | 8,912,000 | +256.5% | 0.01% | +175.0% |
| Q2 2020 | $2,192,600,000 | +6.2% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,064,075,000 | -55.2% | 2,500,000 | -53.1% | 0.00% | -50.0% |
| Q4 2019 | $4,604,318,000 | +0.6% | 5,335,000 | -2.8% | 0.01% | 0.0% |
| Q3 2019 | $4,576,473,000 | -13.5% | 5,491,000 | -10.4% | 0.01% | -27.3% |
| Q2 2019 | $5,289,807,000 | – | 6,127,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS LLC | 300,000 | $298,682 | 0.00% |